期刊文献+

宫颈癌病理分期与临床分期差异性及影响淋巴结转移的危险因素分析 被引量:3

Analysis of the Difference Between Pathological Stage and Clinical Stage of Cervical Cancer and the Risk Factors Influencing Lymph Node Metastasis
下载PDF
导出
摘要 目的探究宫颈癌病理分期与临床分期差异性及影响淋巴结转移的危险因素,以此为临床提供科学的理论作为参考。方法纳入80例宫颈癌患者临床资料进行回顾性分析,针对患者的病理分期和临床分期进行分析,并予以比较,同时了解淋巴结转移的危险因素。结果临床分期ⅠA、ⅠB、ⅡA、ⅡB期符合率分别为66.67%、62.50%、57.14%、53.33%,临床分期总符合率为60.00%。单因素分析显示,有/无淋巴结转移在临床分期、有无化疗、肌层浸润深度、宫旁组织浸润、肿瘤直径各因素方面差异有统计学意义(P<0.05)。Logistic多因素分析显示,高临床分期、有化疗、肌层浸润深度>1/2肌层、有宫旁组织浸润、肿瘤直径≥4cm是影响淋巴结转移的独立危险因素(P<0.01)。结论在宫颈癌的分期中,临床分期相较于病理分期符合率偏低,临床分期、是否化疗、肌层浸润深度、宫旁组织浸润、肿瘤直径等是淋巴结转移的危险因素。 Objective To explore the difference between pathological and clinical stages of cervical cancer and the risk factors affecting lymph node metastasis,so as to provide scientific theories for clinical reference.Methods The clinical data of 80 patients with cervical cancer were retrospectively analyzed.The pathological stage and clinical stage of the patients were analyzed and compared,and the risk factors of lymph node metastasis were also understood.Results The clinical staging Ⅰ,Ⅰ B,A and B ⅡⅡ coincidence rate was 66.67%(8/12),62.50%(20/32),57.14%(12/21),53.33%(8/15),clinical staging total coincidence rate was60.00%(48/80).Univariate analysis showed that there were statistically significant differences in clinical stage,chemotherapy,depth of muscular layer infiltration,periuterine tissue infiltration,and tumor diameter with or without lymph node metastasis(P<0.05).Logistic multivariate analysis showed that high clinical stage,chemotherapy,muscular layer infiltration depth>1/2 muscular layer,periuterine tissue infiltration,and tumor diameter ≥4 cm were independent risk factors for lymph node metastasis(P<0.01).Conclusion In the stage of cervical cancer,the coincidence rate of clinical stage is lower than that of pathological stage.Clinical stage,chemotherapy,depth of muscle layer infiltration,invasion of parietal tissue and tumor diameter are risk factors for lymph node metastasis.
作者 刘英霞 黄卓雅 钟鸣 陈明铨 赵文丽 Liu Yingxia;Huang Zhuoya;Zhong Ming;Chen Mingquan;Zhao Wenli(Department of Pathology,Huizhou First People's Hospital,Huizhou 516000,China;Department of Pathology,Huizhou Central People's Hospital,Huizhou 516000,China)
出处 《哈尔滨医药》 2021年第3期29-31,共3页 Harbin Medical Journal
关键词 宫颈癌 病理分期 临床分期 差异 淋巴结转移 危险因素 Cervical cancer Pathological stage Clinical stages Differences Lymph node metastasis Risk factors
  • 相关文献

参考文献6

二级参考文献61

  • 1刘文欣,李文录.63例40岁以下浸润性宫颈癌的临床与预后分析[J].中国肿瘤临床,2004,31(19):1101-1105. 被引量:15
  • 2余健,张国楠,谢瑞梦,樊英,田昌英.宫颈癌术后复发60例临床分析[J].中国实用妇科与产科杂志,2005,21(3):161-162. 被引量:10
  • 3王瑾晖,杨佳欣,沈铿,郎景和,王博诚,朱朝辉.PET在监测宫颈癌复发中的应用[J].现代妇产科进展,2006,15(12):911-913. 被引量:4
  • 4李相生,周纯武,戴景蕊,赵心明,蒋力明.早期子宫颈癌术后复发或转移的CT诊断[J].中国临床医学影像杂志,2007,18(10):719-721. 被引量:6
  • 5侯亚君.宫颈癌放疗后肺转移157例分析[J].中华肿瘤杂志,1986,8(4):215-217.
  • 6Kanthan R, Senger JL,Diudea D. Pulmonary lymphangiticcarcinomatosis from squamous cell carcinoma of the cervix[J].World J Surg Oncol, 2010, 8:107.
  • 7Chung HH, Kim SK, Kim TH, et al. Clinical impact ofFDG-PET imaging in post-therapy surveillance of uterinecervical cancer: from diagnosis to prognosis[J]. Gynecol Oncol,2006, 103(1):165-170.
  • 8Reinhardt MJ, Wiethoelter N, Matthies A, et al. PET recognitionof pulmonary metastases on PET/CT imaging: impact ofattenuation-corrected and non-attenuation-corrected PET images[J], Eur J Nucl Med Mol Imaging, 2006,33(2):134-139.
  • 9Biewenga P, van der Velden J, Mol BW, et al. Prognostic modelfor survival in patients with early stage cervical cancerfj].Cancer,2011, 117(4):768-776.
  • 10Nakanishi T, Ishikawa H, Nawa A, et al. The significance oftumor size in clinical stage I B cervical cancer: can a cut-offfigure be determined?[J]. Int J Gynecol Cancer, 2000, 10(5):397-401.

共引文献60

同被引文献37

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部